<dd id='3H1za'><tbody id='EvLpr'><td id='ykY9X'><optgroup id='fBbJG'><strong id='P6sRo'></strong></optgroup><address id='Ba22M'><ul id='PnqE7'></ul></address><big id='2QQ0I'></big></td><table id='jihND'></table></tbody><pre id='DuvF1'></pre></dd><span id='3dmLJ'><b id='8oilJ'></b></span>
<dfn id='vcaDn'><optgroup id='UdtDS'></optgroup></dfn><tfoot id='DWoYD'><bdo id='tLb14'><div id='36zL0'></div><i id='WcVPw'><dt id='f2ygo'></dt></i></bdo></tfoot>
<ul id='NmbtM'></ul>
<fieldset id='q0TtI'></fieldset>
諾華制藥宣布，國(guo)家藥品監督(du)管理局于6月1日批準諾欣妥?（沙庫巴曲纈沙坦）用(yong)于治療原發(fa)性高血壓。
<small id='v8222'></small><noframes id='v8222'>
<tbody id='v8222'></tbody>
<bdo id='v8222'></bdo><ul id='v8222'></ul>
